Merz Therapeutics has announced that Dan Staner will take on the role of President, Region Europe, effective February 1, 2026. In this position, Staner will be responsible for leading the company’s European operations and supporting continued growth across the region as Merz Therapeutics advances its strategic priorities.
Health Technology Insights: Solventum Wins Diamond HIRC Badge for Top Supply Chain Strength
Dan Staner will report directly to Chief Executive Officer Stefan König and will become a member of the Therapeutics Executive Team. His appointment reflects Merz Therapeutics’ focus on strengthening regional leadership and building the capabilities needed to support long-term expansion in key European markets.
Stefan König said that Staner brings extensive experience in building and growing biopharmaceutical organizations throughout Europe. He noted that Dan’s strong commercial background, strategic insight, and deep understanding of regional healthcare landscapes will play an important role in expanding patient access to Merz Therapeutics’ treatments and reinforcing the company’s presence across Europe. König added that the leadership team is pleased to welcome Staner as the company enters its next phase of growth.
Health Technology Insights: OrthAlign Expands Lantern Hip Platform for Posterior THA
Over the course of his career, Staner has held a range of senior leadership roles within the biopharmaceutical sector. His experience includes overseeing country and regional profit and loss responsibilities, leading major product launches, and managing large cross-functional teams. He has guided organizations through periods of change and expansion while building productive relationships with healthcare partners and ensuring that innovative therapies reach patients.
As President, Region Europe, Staner will focus on driving commercial performance, strengthening the regional product portfolio, and maintaining close alignment with the company’s global strategy. He will work in collaboration with country leaders, functional teams, and global colleagues to further develop Merz Therapeutics’ footprint in Europe and support sustainable value creation over the long term.
Staner succeeds Marcus Gollub, who stepped down from his role as President, Region Europe at the end of 2025 following a planned and orderly leadership transition.
Health Technology Insights: Ferronova Raises $6 Million to Boost Image-Guided Cancer Surgery
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
